HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
6-Chloro-2-methyl-2,3-dihydropyridazin-3-one
6-chloro-2-methylpyridazin-3(2H)-one · 6-chloro-2-methylpyridazin-3-one · 6-Chloro-2-Methyl-2H-pyridazin-3-one · 3(2H)-Pyridazinone, 6-chloro-2-methyl- · 6-chloro-2-methyl-2,3-dihydropyridazin-3-one - [C81076]

Identifikatoren & physikalische Daten
| CAS No. | 10071-38-2 |
|---|---|
| Summenformel | C5H5ClN2O |
| Durchschnittliche Molmasse | 144,56 g/mol |
| Monoisotopische Masse | 144,00904046 g/mol |
| SMILES | Cn1nc(Cl)ccc1=O |
| InChIKey | IMBNTYIRTCQBRJ-UHFFFAOYSA-N |
| PubChem CID | 2783607 |
| EC No. | 855-216-5 |
| DTXSID | DTXSID00382671 |
Chemische & physikalische Eigenschaften
| XLogP | 0,5 |
|---|---|
| Polarare Oberfläche (TPSA) | 32,7 |
| H-Brücken-Donoren | 0 |
| H-Brücken-Akzeptoren | 2 |
| Frei drehbare Bindungen | 0 |
| Schwere Atome | 9 |
| Formalladung | 0 |
| Komplexität | 197 |
| Schmelzpunkt | 92-94 °C |
| Siedepunkt | 210.7±23.0 °C(Predicted) |
| Dichte | 1.37±0.1 g/cm3(Predicted) |
| Lagerbedingungen | under inert gas (nitrogen or Argon) at 2-8°C |
| pKa (Säurekonstante) | -1.47±0.70(Predicted) |
| InChI | InChI=1S/C5H5ClN2O/c1-8-5(9)3-2-4(6)7-8/h2-3H,1H3 |
| InChIKey | IMBNTYIRTCQBRJ-UHFFFAOYSA-N |
| SMILES | C1(=O)N(C)N=C(Cl)C=C1 |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 4 (100%) |
| Alarmwort | Warnung |
| Gefahrenhinweise | Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302 |
Anwendungen & Verwendung
Verwenden
6-Chloro-2-methylpyridazin-3(2H)-one is used in the preparation of histamine H3 receptor agonists for the treatment of sleeping disorders.